共 49 条
- [1] Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) StudyCARDIOLOGY AND THERAPY, 2020, 9 (02) : 505 - 521Mullasari, Ajit
- [2] Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter StudyJOURNAL OF PAIN, 2014, 15 (08): : 835 - 844Yu, ShiyingShen, WeiYu, LuHou, YanyanHan, JohnRichards, Henry M.
- [3] Adherence With Once Daily Versus Twice Daily Carvedilol in Patients With Heart Failure: The Compliance and Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients With Heart Failure (CASPER) TrialJOURNAL OF CARDIAC FAILURE, 2009, 15 (05) : 385 - 393Udelson, James E.Pressler, Susan J.Sackner-Bernstein, JonathanMassaro, JosephOrdronneau, PaulLukas, Mary AnnHauptman, Paul J.
- [4] Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Crossover StudyJOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (04) : 712 - 720Ridgway, DerrySopata, MaciejBurneckis, ArvydasJespersen, LillianAndersen, Christine
- [5] A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patientsJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 542 - 547Inoue, SatoshiSaito, YojiTsuneto, SatoruAruga, EtsukoTakahashi, HiroshiUemori, Mitsutoshi
- [6] Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tabletCURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2365 - 2375Lux, Eberhard AlbertJanecki, MarcinMaritz, Martina Alice
- [7] Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label comparative, single-center studyCLINICAL TRANSPLANTATION, 2018, 32 (09)Shin, Min-HoSong, Gi-WonLee, Sung-GyuHwang, ShinKim, Ki-HunAhn, Chul-SooMoon, Deok-BogHa, Tae-YongJung, Dong-HwanPark, Gil-ChunYun, Young-InKim, Wan-JunKang, Woo-HyoungKim, Seok-HwanJiang, HongsiLee, SungminTak, Eun-Young
- [8] Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 TrialANNALS OF TRANSPLANTATION, 2021, 26Faravardeh, ArmanAkkina, SanjeevVillicana, RafaelGuerra, GiselleMoten, Misbah A.Meier-Kriesche, UlfStevens, Daniel R.Patel, Samir J.Bunnapradist, Suphamai
- [9] A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer painCLINICAL THERAPEUTICS, 2007, 29 (01) : 49 - 60Beaulieu, Andre D.Peloso, PaulBensen, WilliamClark, Alexander J.Watson, C. Peter N.Gardner-Nix, JacquelineThomson, G.Piraino, Paula S.Eisenhoffer, JohnHarsanyi, ZoltanDarke, Andrew C.
- [10] LONG-TERM OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS CONVERTING FROM TWICE-DAILY, IMMEDIATE-RELEASE TACROLIMUS TO ONCE-DAILY, PROLONGED-RELEASE TACROLIMUS IN ASIAN COUNTRIES: 3-YEAR INTERIM ANALYSIS OF THE MULTICENTER, NONINTERVENTIONAL CHORUS STUDYTRANSPLANTATION, 2020, 104 (09) : S612 - S612Yang, JaeseokWatarai, YoshihikoAnaokar, SwapneelBlogg, Martin